Notification of cessation of securities - RHT

Dear investors,

We are pleased to announce that Resonance Health Limited has reported the cessation of 1,706,991 performance rights (RHTAB) due to the expiry of options or other convertible securities without exercise or conversion on October 27, 2025.

This new announcement is in line with our commitment to transparency and accountability to our stakeholders. The issued capital of the entity now comprises 470,761,315 fully paid ordinary securities (RHT) and 14,054,666 unquoted equity securities, including performance rights.

We welcome any questions or inquiries you may have regarding this announcement. Your trust and support are essential to the growth and success of Resonance Health Limited.

Thank you for your continued confidence in our company.

Sincerely,

Management Team at Resonance Health Limited